|
1
|
Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer.
|
Clin Cancer Res
|
2006
|
3.17
|
|
2
|
Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.
|
J Nucl Med
|
2002
|
2.54
|
|
3
|
Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies.
|
J Nucl Med
|
2005
|
1.87
|
|
4
|
Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer.
|
J Nucl Med
|
2005
|
1.59
|
|
5
|
Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma.
|
J Nucl Med
|
2014
|
1.52
|
|
6
|
Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas.
|
J Nucl Med
|
2006
|
1.40
|
|
7
|
Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs.
|
J Nucl Med
|
2003
|
1.32
|
|
8
|
Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis.
|
J Nucl Med
|
2005
|
1.28
|
|
9
|
Kinetics of 3'-deoxy-3'-[F-18]fluorothymidine uptake and retention in dogs.
|
Mol Imaging Biol
|
2002
|
0.94
|
|
10
|
Effect of p53 activation on cell growth, thymidine kinase-1 activity, and 3'-deoxy-3'fluorothymidine uptake.
|
Nucl Med Biol
|
2004
|
0.89
|
|
11
|
New routes to N-alkylated cyclic sulfamidates.
|
J Org Chem
|
2002
|
0.83
|
|
12
|
A simple quantitative assay for the activity of thymidine kinase 1 in solid tumors.
|
Nucl Med Biol
|
2007
|
0.75
|